Search

Kristin Ann Vajda

Examiner (ID: 10363, Phone: (571)270-5232 , Office: P/1626 )

Most Active Art Unit
1622
Art Unit(s)
4131, 1622, 1626
Total Applications
2296
Issued Applications
1831
Pending Applications
129
Abandoned Applications
372

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18213600 [patent_doc_number] => 20230059865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => METHODS AND COMPOSITIONS FOR MODULATING SPLICING [patent_app_type] => utility [patent_app_number] => 17/502824 [patent_app_country] => US [patent_app_date] => 2021-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 140025 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 383 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17502824 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/502824
Methods and compositions for modulating splicing Oct 14, 2021 Issued
Array ( [id] => 17851827 [patent_doc_number] => 20220281869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/490482 [patent_app_country] => US [patent_app_date] => 2021-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67931 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17490482 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/490482
Purinones as ubiquitin-specific protease 1 inhibitors Sep 29, 2021 Issued
Array ( [id] => 18844466 [patent_doc_number] => 20230406870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRONSTED ACIDS [patent_app_type] => utility [patent_app_number] => 18/030728 [patent_app_country] => US [patent_app_date] => 2021-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030728 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/030728
Process for preparing dimeric phosphazene derived BrOnsted acids Sep 27, 2021 Issued
Array ( [id] => 17473961 [patent_doc_number] => 20220081465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => C7 SUBSTITUTED OXYSTEROLS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/476153 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29197 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476153 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/476153
C7 substituted oxysterols and methods of use thereof Sep 14, 2021 Issued
Array ( [id] => 18739513 [patent_doc_number] => 20230348450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE [patent_app_type] => utility [patent_app_number] => 18/025847 [patent_app_country] => US [patent_app_date] => 2021-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22686 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025847 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025847
CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE Sep 13, 2021 Pending
Array ( [id] => 20213505 [patent_doc_number] => 12410147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Surfactants [patent_app_type] => utility [patent_app_number] => 18/043178 [patent_app_country] => US [patent_app_date] => 2021-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6168 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043178 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/043178
Surfactants Sep 2, 2021 Issued
Array ( [id] => 17311911 [patent_doc_number] => 20210400959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => DISINFECTING COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/462131 [patent_app_country] => US [patent_app_date] => 2021-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9404 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17462131 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/462131
Disinfecting composition Aug 30, 2021 Issued
Array ( [id] => 17343576 [patent_doc_number] => 20220009907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => METALLOENZYME INHIBITOR COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/462909 [patent_app_country] => US [patent_app_date] => 2021-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40919 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 271 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17462909 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/462909
Metalloenzyme inhibitor compounds Aug 30, 2021 Issued
Array ( [id] => 19165931 [patent_doc_number] => 11981820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-14 [patent_title] => Ultra bright dimeric or polymeric dyes [patent_app_type] => utility [patent_app_number] => 17/458938 [patent_app_country] => US [patent_app_date] => 2021-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14983 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 316 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458938 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/458938
Ultra bright dimeric or polymeric dyes Aug 26, 2021 Issued
Array ( [id] => 17315981 [patent_doc_number] => 20210405029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => COMPOUNDS INHIBITING NEF-CALNEXIN INTERACTION [patent_app_type] => utility [patent_app_number] => 17/410882 [patent_app_country] => US [patent_app_date] => 2021-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13146 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410882 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/410882
Compounds inhibiting Nef-calnexin interaction Aug 23, 2021 Issued
Array ( [id] => 19701642 [patent_doc_number] => 12195654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-14 [patent_title] => Luminescent particle and compound [patent_app_type] => utility [patent_app_number] => 17/407146 [patent_app_country] => US [patent_app_date] => 2021-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 15127 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17407146 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/407146
Luminescent particle and compound Aug 18, 2021 Issued
Array ( [id] => 17829982 [patent_doc_number] => 20220267286 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2022-08-25 [patent_title] => 2-THIOXOTHIAZOLIDIN-4-ONE DERIVATIVES ACTIVE AS TRANSTHYRETIN LIGANDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/405506 [patent_app_country] => US [patent_app_date] => 2021-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405506 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/405506
2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof Aug 17, 2021 Issued
Array ( [id] => 17533550 [patent_doc_number] => 20220112159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME [patent_app_type] => utility [patent_app_number] => 17/405989 [patent_app_country] => US [patent_app_date] => 2021-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62032 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405989 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/405989
Sulfonylureas and related compounds and use of same Aug 17, 2021 Abandoned
Array ( [id] => 17829982 [patent_doc_number] => 20220267286 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2022-08-25 [patent_title] => 2-THIOXOTHIAZOLIDIN-4-ONE DERIVATIVES ACTIVE AS TRANSTHYRETIN LIGANDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/405506 [patent_app_country] => US [patent_app_date] => 2021-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405506 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/405506
2-thioxothiazolidin-4-one derivatives active as transthyretin ligands and uses thereof Aug 17, 2021 Issued
Array ( [id] => 17258432 [patent_doc_number] => 20210371417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/396312 [patent_app_country] => US [patent_app_date] => 2021-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46281 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -123 [patent_words_short_claim] => 376 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17396312 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/396312
AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS Aug 5, 2021 Abandoned
Array ( [id] => 18428645 [patent_doc_number] => 11673855 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-13 [patent_title] => Voltage gated sodium channel imaging agents [patent_app_type] => utility [patent_app_number] => 17/395356 [patent_app_country] => US [patent_app_date] => 2021-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 19733 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395356 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/395356
Voltage gated sodium channel imaging agents Aug 4, 2021 Issued
Array ( [id] => 19510491 [patent_doc_number] => 20240342177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => METHODS OF TREATING BRAIN CANCER [patent_app_type] => utility [patent_app_number] => 18/294806 [patent_app_country] => US [patent_app_date] => 2021-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294806 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/294806
METHODS OF TREATING BRAIN CANCER Aug 3, 2021 Pending
Array ( [id] => 18362718 [patent_doc_number] => 20230144309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => CRYSTALLINE FORM OF L-GLUFOSINATE AMMONIUM SALT AND PROCESS FOR PRODUCTION THEREOF [patent_app_type] => utility [patent_app_number] => 17/635491 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635491 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/635491
Crystalline form of L-glufosinate ammonium salt and process for production thereof Jul 29, 2021 Issued
Array ( [id] => 17742579 [patent_doc_number] => 11390636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Organic solvent processable carbon phosphonitride pre-polymers [patent_app_type] => utility [patent_app_number] => 17/443750 [patent_app_country] => US [patent_app_date] => 2021-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 2014 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443750 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/443750
Organic solvent processable carbon phosphonitride pre-polymers Jul 26, 2021 Issued
Array ( [id] => 18612246 [patent_doc_number] => 20230278978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => THIOPHENE HSD17B13 INHIBITORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/006059 [patent_app_country] => US [patent_app_date] => 2021-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -120 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006059 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/006059
Thiophene HSD17B13 inhibitors and uses thereof Jul 22, 2021 Issued
Menu